791 related articles for article (PubMed ID: 1281207)
1. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.
Rot A; Krieger M; Brunner T; Bischoff SC; Schall TJ; Dahinden CA
J Exp Med; 1992 Dec; 176(6):1489-95. PubMed ID: 1281207
[TBL] [Abstract][Full Text] [Related]
2. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.
Dahinden CA; Geiser T; Brunner T; von Tscharner V; Caput D; Ferrara P; Minty A; Baggiolini M
J Exp Med; 1994 Feb; 179(2):751-6. PubMed ID: 7507512
[TBL] [Abstract][Full Text] [Related]
3. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.
Kapp A; Zeck-Kapp G; Czech W; Schöpf E
J Invest Dermatol; 1994 Jun; 102(6):906-14. PubMed ID: 7516398
[TBL] [Abstract][Full Text] [Related]
4. Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-beta family.
Vaddi K; Newton RC
J Leukoc Biol; 1994 Jun; 55(6):756-62. PubMed ID: 7515094
[TBL] [Abstract][Full Text] [Related]
5. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors.
Bischoff SC; Krieger M; Brunner T; Rot A; von Tscharner V; Baggiolini M; Dahinden CA
Eur J Immunol; 1993 Mar; 23(3):761-7. PubMed ID: 7680615
[TBL] [Abstract][Full Text] [Related]
6. IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1.
Chuluyan HE; Schall TJ; Yoshimura T; Issekutz AC
J Leukoc Biol; 1995 Jul; 58(1):71-9. PubMed ID: 7542307
[TBL] [Abstract][Full Text] [Related]
7. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3.
Weber M; Uguccioni M; Ochensberger B; Baggiolini M; Clark-Lewis I; Dahinden CA
J Immunol; 1995 Apr; 154(8):4166-72. PubMed ID: 7535823
[TBL] [Abstract][Full Text] [Related]
8. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
9. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.
Jose PJ; Griffiths-Johnson DA; Collins PD; Walsh DT; Moqbel R; Totty NF; Truong O; Hsuan JJ; Williams TJ
J Exp Med; 1994 Mar; 179(3):881-7. PubMed ID: 7509365
[TBL] [Abstract][Full Text] [Related]
10. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8.
Meurer R; Van Riper G; Feeney W; Cunningham P; Hora D; Springer MS; MacIntyre DE; Rosen H
J Exp Med; 1993 Dec; 178(6):1913-21. PubMed ID: 7504053
[TBL] [Abstract][Full Text] [Related]
11. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.
Uguccioni M; D'Apuzzo M; Loetscher M; Dewald B; Baggiolini M
Eur J Immunol; 1995 Jan; 25(1):64-8. PubMed ID: 7531149
[TBL] [Abstract][Full Text] [Related]
12. RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells.
Kimata H; Yoshida A; Ishioka C; Fujimoto M; Lindley I; Furusho K
J Exp Med; 1996 May; 183(5):2397-402. PubMed ID: 8642352
[TBL] [Abstract][Full Text] [Related]
13. C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation.
Lukacs NW; Standiford TJ; Chensue SW; Kunkel RG; Strieter RM; Kunkel SL
J Leukoc Biol; 1996 Nov; 60(5):573-8. PubMed ID: 8929547
[TBL] [Abstract][Full Text] [Related]
14. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils.
Takafuji S; Tadokoro K; Ito K; Dahinden CA
Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519
[TBL] [Abstract][Full Text] [Related]
15. Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines.
Wang JM; McVicar DW; Oppenheim JJ; Kelvin DJ
J Exp Med; 1993 Mar; 177(3):699-705. PubMed ID: 7679707
[TBL] [Abstract][Full Text] [Related]
16. Chemotactic agonists induce cytokine generation in eosinophils.
Miyamasu M; Hirai K; Takahashi Y; Iida M; Yamaguchi M; Koshino T; Takaishi T; Morita Y; Ohta K; Kasahara T
J Immunol; 1995 Feb; 154(3):1339-49. PubMed ID: 7529800
[TBL] [Abstract][Full Text] [Related]
17. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
[TBL] [Abstract][Full Text] [Related]
19. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes.
Schall TJ; Bacon K; Camp RD; Kaspari JW; Goeddel DV
J Exp Med; 1993 Jun; 177(6):1821-6. PubMed ID: 7684437
[TBL] [Abstract][Full Text] [Related]
20. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
